Journal of Nanomaterials

Journal of Nanomaterials / 2021 / Article
Special Issue

Synthesis and Application of Nanoparticles from Microorganisms and Plants

View this Special Issue

Research Article | Open Access

Volume 2021 |Article ID 6676555 |

Seyedeh Narjes Abootalebi, Seyyed Mojtaba Mousavi, Seyyed Alireza Hashemi, Eslam Shorafa, Navid Omidifar, Ahmad Gholami, "Antibacterial Effects of Green-Synthesized Silver Nanoparticles Using Ferula asafoetida against Acinetobacter baumannii Isolated from the Hospital Environment and Assessment of Their Cytotoxicity on the Human Cell Lines", Journal of Nanomaterials, vol. 2021, Article ID 6676555, 12 pages, 2021.

Antibacterial Effects of Green-Synthesized Silver Nanoparticles Using Ferula asafoetida against Acinetobacter baumannii Isolated from the Hospital Environment and Assessment of Their Cytotoxicity on the Human Cell Lines

Academic Editor: Shahid Ali
Received04 Dec 2020
Revised11 Apr 2021
Accepted16 Apr 2021
Published03 May 2021


Acinetobacter baumannii (A. baumannii) is a dangerous nosocomial pathogen in intensive care units, causing fatal clinical challenges and mortality. In this study, the green synthesis of silver nanoparticles (AgNPs) using the extract of Ferula asafetida and the chemical synthesis of AgNPs were carried out to evaluate their effects on A. baumannii bacterial strain and a human adenocarcinoma cell line. The NPs were characterized using several techniques, including field emission-scanning electron microscopy, X-ray diffraction, energy-dispersive X-ray spectrometry, UV-visible spectroscopy, and Fourier-transform infrared spectroscopy. After synthesis, the arrangement of AgNPs was confirmed based on the maximum absorption peak at 450 nm. The results showed that the AgNPs had a hexagonal structure. The antimicrobial activity of biogenic NPs significantly increased and reached a minimum inhibitory concentration of 2 μg/mL. The nanomaterials did not exhibit any toxic effects on the human cell line at certain concentrations and showed improvements compared to chemically synthesized AgNPs. However, at higher concentrations (100 μg/mL), the cytotoxicity increased. Finally, it was concluded that biosynthesized AgNPs had significant antimicrobial effects on A. baumannii isolated from intensive care units.

1. Introduction

The ESKAPE pathogens, including Enterobacter spp., Pseudomonas aeruginosa, Enterococcus faecium, Acinetobacter baumannii, Klebsiella pneumoniae, and Staphylococcus aureus, have developed multidrug resistance in clinics. These pathogens are associated with high levels of lethargy and mortality, imposing significant costs on patients and healthcare systems [1]. Acinetobacter baumannii is a Gram-negative, nonfastidious, nonfermenting, nonmotile coccobacillus responsible for respiratory infections, pneumonia, and urinary tract infections [2]. This pathogen attacks unhealthy hospitalized patients and severely damages their skin and the respiratory tract [3]. It can also proliferate over different temperatures and pH ranges and use different materials as a carbon source [1].

Ventilator-associated pneumonia caused by A. baumannii is responsible for high mortality rates and healthcare costs, particularly in intensive care units (ICUs). There is an urgent need to develop successful pharmaceuticals instead of beta-lactams (carbapenem) against this nosocomial pathogen [4]. Among metallic NPs, silver NPs (AgNPs) are attractive biotic nanomaterials used for biomedical purposes [5]. These NPs have been applied in different scientific areas, such as environmental science, biomedicine, chemistry, and building industries, due to their unique properties. Besides, they play a remarkable role in nanotechnology and nanoscience, especially in nanomedicine [6]. They exhibit anti-inflammatory, antioxidant, antitumor, and antimicrobial properties, leading to their broad applications in biomedicine [7]. Overall, the biogenic synthesis of NPs is considered a valuable strategy by providing more profitable NPs with higher stability and biocompatibility [8].

There are around 130 Ferula species (Apiaceae) worldwide, thirty of which are found in Iran. There are several reports on the antibacterial, antidiabetic, hypotensive, antispasmodic, and antiviral (HIV, H1N1, HRV, and HSV) effects of Ferula asafoetida (F. asafoetida). One of the specific characteristics of this plant is its pungent odor produced by a nonubiquitous compound, as well as significant pharmacological properties due to the presence of volatile sulfide constituents [9]. Since the antibacterial mechanism of AgNPs appears to involve interactions with the bacterial cell membrane, producing free radicals and resulting in growth inhibition, we hypothesized that the extract of F. asafoetida might improve the antibacterial effects of AgNPs. Therefore, it is essential to select a proper reducing agent for biogenic AgNP synthesis.

Although several medicinal plant extracts containing different reducing agents, such as phenolic, polyphenol, and flavonoid compounds, have been widely applied for the green synthesis of AgNP [1012], there are few reports on the use of F. asafoetida and its natural constituents for the biosynthesis of AgNPs. Ferula asafoetida contains many natural metabolites, including proteins, polysaccharides, alkaloids, and alcoholic compounds, which can act as reducing agents and exert beneficial biological effects. Therefore, the combination of AgNPs with F. asafoetida may lead to the development of a promising antimicrobial agent against serious infectious diseases with reduced cytotoxicity.

For the first time, the present study is aimed at investigating the potential application of the aqueous extract of F. asafoetida (FerEX) for the green synthesis of AgNPs, evaluating its effect on A. baumannii, isolated from patients admitted to the pediatric ICU (PICU), and examining its potential cytotoxic effects.

2. Methods

2.1. Isolation of Bacterial Strains from the PICU

Samples of A. baumannii were collected from the blood, respiratory emissions, urine, and skin ulcers. They were collected from patients hospitalized in the PICU of Namazi Hospital, Shiraz, Iran. They were first transferred to tubes containing normal saline (0.9%) and serially diluted tenfold. The microbiological procedures were carried out using routine laboratory tests. After transferring the microbial plates to the microbiology research facility, cultures were prepared in MacConkey agar plates (Merck, Germany). Single colonies were confined and distinguished using routine laboratory bacteriological tests based on their biochemical, culture, and microbiological features on Gram staining [13, 14].

2.2. Extraction of the Aqueous Extract of F. asafoetida

The leaves and other aerial parts of F. asafoetida were collected from the southern regions of Iran (Lar, Iran) in March 2019. The plant parts were then dried at room temperature. Next, the voucher specimens of F. asafoetida were deposited in the herbarium of the Department of Plant Protection of Shiraz University (No. #5237). After carefully washing the specimens with deionized water, different parts of F. asafoetida were dehydrated at 18-24°C for 14 days. Next, 41 g of powdered F. asafoetida was added to 500 mL of deionized water in a glass beaker and boiled for 16 hours at 50°C. Next, it was cooled, and the aqueous extract was filtered through a Whatman No. 1 filter paper. The black-brown bottle containing the extract of F. asafoetida (FerEX) was stored at 4°C until further analyses and biological experiments.

Fourier-transform infrared (FTIR) spectroscopy (Series Tensor II, Bruker, USA) was performed for characterization. Also, a gas chromatograph connected to a mass spectrometer (GC/MS, Agilent Technologies 5975C), which was equipped with an HP-5 MS capillary column (length of 30 m, inner diameter of 0.25 mm, and layer thickness of 0.25 μm), was used to analyze the constituents of F. asafoetida. The oven temperature was increased from 60°C to 250°C (5°C per minute) and kept at 250°C for ten minutes. Helium gas was used as a carrier with a flow rate of 1.1 mL/min and ionization energy of 70 eV. The interface temperature was 280°C, and the mass range was 30-600 m/z. The essential oil constituents were identified based on retention indices (by injecting C9-C20 hydrocarbons under the same conditions as essential oil) and comparison with mass spectra, according to Wiley (nl7) and Adams’ mass spectral libraries [15].

2.3. Green Synthesis of AgNPs

For the green synthesis of AgNPs, 5 mL of FerEX was poured into a glass jolt by a sterile pipette. Next, 95 mL of silver nitrate (1 mM AgNO3) was added and shaken at 25°C for 48 hours. Finally, the colored solution was centrifuged at 12,000 rpm for 20 minutes at 4°C and washed centrifugally three times. The obtained mass was dried using a vacuum evaporator, and biogenic F. asafoetida AgNP (Fer@AgNP) powder was stored in a nitrogen-filled container at 4°C.

2.4. Chemical Synthesis of AgNPs

According to a study by Abbaszadegan et al., AgNO3 reduction by NaBH4 was applied to synthesize chemical AgNPs. Briefly, 1 mL of AgNO3 (0.1 mM) was slowly added to 20 mL of NaBH4 (6.2 mM), which was previously chilled using ice and stirring [7]. This reaction was maintained in a dark room for 24 hours, and the mixture was stored at 4°C until further experiments.

2.5. Characterization

In this study, AgNPs and Fer@AgNP were characterized using FTIR spectroscopy (Tensor II, Bruker, USA), field emission-scanning electron microscopy (FE-SEM; Mira III, Tescan), energy-dispersive X-ray spectroscopy (XRD; Series S Max Finder Mira III, Tescan), and EDX mapping (Series S Max Locator Mira III, Tescan).

2.6. Antimicrobial Activity Assessment

A colony of A. baumannii was cultured in Luria–Bertani (LB) broth medium. A 24-hour cultured microbial strain suspension was inoculated into tubes containing 3 mL of Mueller-Hinton broth to obtain a suspension with 0.5 McFarland turbidity. The microorganism was then subjected to three types of antimicrobial tests, according to the Clinical and Laboratory Standards Institute (CLSI) 2018 guidelines, including well diffusion method, broth microdilution, and minimum bactericidal concentration (MBC) assay [16]. For preparation, the desired amounts of NPs were dispersed in a solution of double-distilled water. Next, they were exposed to ultrasonic waves for about one hour.

2.6.1. Well Diffusion Method

The well diffusion method was used to examine the antimicrobial effects in Mueller-Hinton agar plates. For this purpose, 100 μL of the microbial suspension was added to a Mueller-Hinton agar plate and cultured using a sterile swab. A well with a dimension of was prepared on the surface of each agar-containing plate, containing 50 μL of each tested compound; the tested compounds included FerEX, AgNPs, and Fer@AgNPs. Carbapenem was also used as a standard antibiotic, and sterile refined water was used as control. Finally, the bacterial media were incubated at 37°C for 24 hours, and microbial colonies were examined for the developed inhibition zones; the hollow diameters (where no microorganisms grew) were measured and reported in millimeters.

2.6.2. Broth Microdilution

The broth microdilution method was used to determine the minimum inhibitory concentration (MIC) [17]. For this purpose, serial dilutions (0.5-250 μg/mL) of each compound, dissolved in Mueller-Hinton broth, were added to 96-well plates, and the microbial suspensions were immediately added to each well. Microwells containing the culture medium were considered the negative controls, and the wells containing the media and microorganisms without any effective constituents were considered the positive controls (100% viability). Carbapenem was also assessed as a standard antibiotic. Finally, the microplates were transferred to a humidified incubator and maintained overnight at 37°C. The absorption of each well was read at 600 nm using a microplate reader, and the viability percentage of microorganisms in each tested well was calculated compared to the positive control. The concentration of each compound inhibiting the growth of A. baumannii by 90%, as compared to the control group, was considered as the MIC.

2.6.3. MBC Assay

The microorganisms were cultured overnight in a brain-heart infusion (BHI) medium, and a stock with a concentration of 105-106 CFU/mL was prepared. Next, 50 μL of different compounds (concentrations of 0.5 to 250 μg/mL) was added to a 96-well microplate, containing 40 μL of BHI and 10 μL of A. baumannii suspension. The plates were incubated overnight at 37°C. A volume of 10 μL from each tested well (including the controls) was added to a BHI agar plate and transferred to an incubator for another 24 hours at 37°C to examine the bactericidal effect of each compound. The concentration of each compound causing no growth of microorganisms was regarded as the MBC.

2.7. Cytotoxicity Assay (MTT Assay)

The cytotoxicity of Fer@AgNP was evaluated on the MCF-7 human cell line, using the MTT assay, according to a study by Gholami et al. [18]. In this study, the MCF-7 cell line was prepared by the Cell Bank of Pasteur Institute of Iran (NCBI code: C135). The cells were maintained in DMEM medium, containing 25 mM of glucose, 10% fetal bovine serum (FBS), penicillin (100 U/mL), and streptomycin (100 μg/mL). The cells were incubated at 37°C with 5% CO2 at 95% humidity. Briefly, the cell lines were suspended in the RPMI-1640 medium and seeded into a cell culture plate. The cells were maintained under standard conditions (5% CO2, 95% humidity, and temperature of 37°C) for 24 hours.

The RPMI-1640 medium was used to prepare different concentrations of each compound (1-500 μg/mL), which were later added to each well, containing cells attached to the bottom after removing the previous culture medium. The cells were incubated again for 24 hours, and 25 μL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) solution was added to each well and incubated for four hours. To solubilize MTT-formazan crystals, 100 μL of dimethyl sulfoxide (DMSO) was added to the mixture and shaken for ten minutes [19]. An ELISA plate reader (BioTek, Winooski, VT, USA) was also utilized to calculate the absorbance of each well at a wavelength of 540 nm, compared to the equivalent well of untreated cells. Cell viability was calculated using the following equations: where OD represents the optical density and the cell viability percentage is the percentage of living cells after the test.

2.8. Statistical Analysis

The results of biological assays were analyzed using IBM SPSS software. One-way ANOVA, followed by Tukey’s post hoc test, was used to evaluate differences between the groups. All biological experiments (both antimicrobial tests and cytotoxicity assays) were performed in triplicate, and was considered statistically significant.

3. Results and Discussion

For the first time, this study is aimed at evaluating the biogenic synthesis of AgNPs using the extract of F. asafoetida as a reducing agent. This extract contained important biological components, such as proteins and ethylene groups, and could act as a capping/stabilizing agent. Their main components were investigated using a GC/MS apparatus.

3.1. Ferula asafoetida Constituents

A GC/MS apparatus was used to determine the major chemical components of F. asafoetida. The results showed that F. asafoetida contained 35 chemical constituents, including propenyl butyl disulfide (55.4%), α-pinene (1.1%), camphene (0.16%), β-pinene (15.69%), myrcene (1.4%), decane (1.02%), limonene (0.51%), β-ocimene (17.34%), γ-terpinene (0.06%), α-terpinolene (0.41%), carvacrol (0.59%), and n-pentacosane (2.13%). All of the main chemical constituents of F. asafoetida are summarized in Table 1.

NumberKovats indexCompoundsArea (%)Analysis

141107Dipropyl disulfide0.16GC
171163n-Propyl sec-butyl disulfide0.75GC
181172(E)-1-Propenyl sec-butyl disulfide55.4GC
201212Bis(1-methyl propyl) disulfide0.57GC
301506β-Dihydro agarofuran0.11GC

Several studies have investigated the components of F. asafoetida. Although there are some differences in the discovered constituents and their amounts, the main components are nearly the same [20]. Among the distinguished chemical components of F. asafoetida, heptane belongs to the alkane group with seven carbon particles. This colorless liquid is insoluble in polar solvents, with gasoline-like smells. Besides, decane is a profoundly combustible natural compound from the alkene group. This compound is nonpolar and insoluble in water, similar to other alkanes [21].

Moreover, a cyclic monoterpene, namely, limonene, was found in F. asafoetida. It has a smell similar to orange and has been used to synthesize chemical materials in household cleansers and renewable energies. This hydrocarbon can be effectively oxidized in humid environments and may be a chiral particle [22].

Terpineol is a monoterpene derived from petitgrain oil, pine oil, and petroleum. It is commonly used in fragrances, makeup products, and flavors and has a pleasant odor similar to jasmine [23]. Thymol and carvacrol, as two well-known terpenes, revealed significant antioxidant, antifungal, and antibacterial activities. Besides, numerous studies showed their potential on bacterial strains at lower concentrations [24]. These compounds and some other structures found in the plant extract can functionalize AgNPs and significantly improve their biological efficacy.

3.2. Characterization of Biogenic NPs

The FTIR analysis was performed to confirm the functional groups of biomolecules involved in capping, viable stabilization, and reduction of synthesized Fer@AgNP. The FTIR spectra of FerEX and Fer@AgNP (Figure 1) showed nine peaks at 3405, 2427, 2359, 2100, 1788, 1635, 1338, 1048, and 832 cm-1, respectively. The peak at 3405 cm-1 in the chemically synthesized AgNPs was related to the N-H bond of amide and O-H of hydroxy groups, extending to phenols/alcohols or bending/stretching hydrogen-bonded phenols/alcohols in the extract. The peak at 2427 cm-1 was related to the C-H bond of alkanes. Also, the peaks at 2359 cm-1 to 2100 cm-1 were related to C≡N and C≡C stretching in the aromatic/aliphatic compounds.

The peaks at 1788 to 1635 cm-1 were related to the C=C stretching of fragrant compounds. Another study reported that these peaks were related to the carbonyl (C=O) groups of proteins. Besides, the peak at 1338 cm-1 represented the CH3 group of carbohydrates. Also, the peak at 1048 cm-1 was related to alkanes, ethers, esters, alcohols, and the C=O in-plane bending of carboxylic acids. Consistent with previous reports, the peak at 832 cm-1 was related to the =CH stretching of bicyclic monoterpenes [25]. In previous studies, the FTIR bands at 3405, 2100, 1788, 1635, 1048, and 832 cm-1 indicated the properties of AgNPs [26], and the presence of other bands confirmed the proximity of different biomolecules, which played a significant role in stabilizing Fer@AgNP. AbuDalo et al. also concluded that these bands represented the presence of aromatic compounds, alkanes, and amide bonds of proteins and amines in the structure of biogenic AgNPs, which contributed to the production and stability of NPs [27]. In particular, for the C=O bond, a slight shift represented adsorption on the surface and suggested that this bond is related to the hydroxyl group stretching bands in biological macromolecules, such as proteins or polysaccharides found in the F. asafoetida.

In Figure 2, the FE-SEM images of chemical AgNPs and green-synthesized biogenic Fer@AgNPs are presented. As shown in Figure 2, both chemical and biogenic NPs had circular structures, with an average size of for Fer@AgNP and for chemically synthesized AgNP ( for ). Several studies have reported that most biogenic AgNPs have a spherical geometry, with a size range of 5 to 500 nm; however, different biological activities have been reported [27]. Our observations showed that Fer@AgNP had higher colloidal stability than chemically synthesized NPs after seven days of being maintained in the dark at 23-25°C with low particle agglomeration. It seems that the stability of Fer@AgNP is related to steric stabilization by natural surfactants [28] found in the FerEX, as described in Section 3.1.

The constituents of biogenic AgNPs were evaluated by the EDX analysis. The peaks were observed between 2 keV and 5 keV, confirming the presence of Ag. Figure 3 and Table 2 demonstrate the distinct presence of Ag peaks at 3 keV for Fer@AgNPs, which is a specific characteristic of AgNPs with weight and atomic percentages of 11.6% and 7.7%, respectively. The high atomic and weight percentages of organic elements, such as C, N, and O, revealed the possible presence of organic compounds, such as polysaccharides, phenols, and proteins; these compounds have also been reported in some studies [29].

CompoundsElementsIntensityWeight %Atomic %



X-ray diffractometry was used to confirm the crystalline structure of synthesized AgNPs. As shown in Figure 4, the hexagonal structure of Ag crystals was found, with Ag in a cubic form. The X-ray image indicated AgNPs, and a few diffraction peaks were observed at , 44, 65, and 78 corresponding to the (111), (200), (220), and (311) planes, respectively. These peaks might be attributed to the natural components of F. asafoetida, indicating the biogenic synthesis of Fer@AgNP [30]. In some studies, the crystalline structure of biogenic AgNPs synthesized using plant extracts is comparable with the crystalline structure of AgNPs synthesized using F. asafoetida [31, 32]. Equation (2) (Debye-Scherrer equation) was used to measure the average crystalline size of nanoparticles. where is the average size of the nanoparticles, is the Scherrer equation (0.9), is the X-ray radiation wavelength, and is the angular full width at half maximum (FWHM) of XRD peaks at diffraction point [33]. The average crystalline size of the biogenic Fer@AgNP using FerEX was ~42 nm.

As illustrated in Figure 5, a characteristic peak was observed at around 450 nm for AgNPs using UV-VIS spectroscopy (Figure 5(b)). The obtained range, which was consistent with previous reports, was contributed to the AgNP formation. Several studies reported the AgNP formation occurred in the wavelength of 400 to 500 nm [34]. The on-site observations and the UV-VIS spectrogram showed reducing Ag+ ions into Ag0, besides the green synthesis of AgNPs.

3.3. Antibacterial Effects against A. baumannii

The antimicrobial effect of Fer@AgNP against A. baumannii was examined using the well diffusion method, and the results were compared with those obtained for AgNPs synthesized by the chemical method. The data were also evaluated based on the MICs and MBCs. The FerEX created an inhibition hollow against the microorganisms at high concentrations (50-200 μg/mL). As shown in Figure 6, the anti-Acinetobacter effect of all compounds was dose-dependent. The viability of bacterial strains reduced by increasing the concentration of NPs. The Fer@AgNP showed a higher antimicrobial efficacy compared to AgNPs. The mean of three replicates for the width of the inhibition zone (in millimeter) is presented in Table 3.

CompoundsHollow diameter (mm)
1 μg/mL10 μg/mL25 μg/mL50 μg/mL100 μg/mL200 μg/mL


Among the tested compounds, Fer@AgNP showed a more significant inhibitory effect against A. baumannii. At the highest concentration (200 μg/mL), the inhibition zone was measured at for FerEX, for AgNP, and for Fer@AgNP. There was no significant difference between Fer@AgNP and the standard antibiotic (carbapenem). Also, smaller inhibition zones were found for the FerEX. The MIC and MBC were measured to be 31.25 and 31.25 μg/mL for the chemically synthesized NPs and 2 and 2 μg/mL for the biogenic NPs, respectively. These findings revealed that the antimicrobial potential of biogenic NPs was significantly higher than chemical AgNPs (Figure 6 and Table 4). The optimal MIC and MBC were obtained by carbapenem at a concentration of 1 μg/mL. Also, the antimicrobial properties of FerEX were demonstrated at high concentrations ( and ).

CompoundsConcentrations (μg/mL)


Huang et al. synthesized biogenic AgNPs using a plant extract of Cacumen platycladi and evaluated their antimicrobial effects and mechanism [35]. According to their results, the MIC and MBC against Staphylococcus aureus and Escherichia coli were 5.4 and 5.4 μg/mL and 1.4 and 27 μg/mL, respectively; the present results showed better MIC and MBC values than the study by Huang and colleagues. Another study evaluated the antimicrobial effects of biogenic AgNPs using aloe vera. The MIC of aloe vera-synthesized AgNPs against S. epidermidis was 10 μg/mL, weaker than our finding [36]. This significant biological effect might be due to the strong antimicrobial effects of functional groups on Fer@AgNP, such as thiol groups.

The similar MBC and MIC values of nanomaterials compared to carbapenem revealed that their antimicrobial mechanisms could be bactericidal; this argument has been proposed in several previous studies [37]. On the other hand, the differences between the MIC and MBC values of FerEX might be attributed to the bacteriostatic activity of this natural product. Several studies have shown that AgNPs, green synthesized by plant extracts, have remarkable antibacterial effects [3840]. These biogenic AgNPs significantly inhibit the growth of a wide range of microbial pathogens, such as Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, Azotobacter chroococcum, Bacillus licheniformis, Staphylococcus aureus, and Candida albicans, which are involved in more common hospital-acquired infections [33, 41].

Biogenic AgNPs showed the most significant antimicrobial activity against A. baumannii, a dangerous pathogen in ICUs and PICUs. Our results revealed the higher viability of biogenic AgNPs against this bacterial strain than chemically synthesized AgNPs. In this regard, Singh et al. measured the MIC against A. baumannii to be 16 μg/mL, while the present study found a MIC of 2 μg/mL [41]. They proposed a synergistic relationship between bacteriogenic AgNPs and some antibiotics. They clarified the potential role of these antibiotics in combination with AgNPs in facilitating the permeabilization of AgNPs through the external cell layer by displacing Mg2+ or Ca2+, especially in the lipopolysaccharide layer. Inhibition of UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) by natural compounds is another in vivo mechanism that disables A. baumannii and increases the opsonization of bacteria by macrophages [42]. This may suggest that functional groups on the surface of Fer@AgNP, particularly compounds containing thiol groups, help NPs to attach to lipopolysaccharides (LPS) of Gram-negative A. baumannii through biogenic synthesis and facilitate the integration of NPs.

Bhatnager et al. studied the antibacterial activity of F. asafetida, extracted with water (W), hexane (H), ethanol (E), and petroleum ether (P). They used biomass to calculate the zone of inhibition (E. coli: 8 mm (P), 8 mm (H), 12 mm (W), and 7 mm (E); S. aureus: 7 mm (P), 11 mm (H), 7 mm (W), and 7 mm (E); K. pneumoniae: 7 mm (P), 9 mm (H), 8 mm (W), and 8 mm (E); S. flexneri: 13 mm (P), 15 mm (H), 7 mm (W), and 11 mm (E); and E. faecalis: 8 mm (P), 7 mm (H), 9 mm (W), and 7 mm (E)) [43]. Although Bhatnager et al. did not investigate the concentration dependence of the antibacterial effect of FerEXs, the antimicrobial activity was observed at the highest concentrations (up to 100 μg/mL). The anti-Acinetobacter effect of AgNPs was increased when they were synthesized in the presence of the aqueous extract of FerEX. The increased antimicrobial effect of biogenic AgNP compared to chemical AgNP may be due to the combination of NPs with the antibacterial constituents of FerEX extract, especially thiol-containing substances.

The MIC and MBC values of Fer@AgNP against A. baumannii were more compelling than those obtained in other experiments using other plant extracts or living microorganisms from different plants or living organisms (Neurada procumbens [44], Xanthomonas spp. [45], Eucalyptus citriodora [46], and Acinetobacter calcoaceticus) to synthesize biogenic AgNPs. The bacterial growth was inhibited at a concentration range from 20 μg/mL to 500 μg/mL. Besides, the MIC and MBC values of Fer@AgNP revealed its higher antibacterial potential than chemically synthesized AgNPs. The superior antibacterial activity of Fer@AgNP compared to its chemically synthesized counterpart may be attributed to the smaller size of NPs, which offers a larger surface/volume ratio and results in their superior binding and transfer through the bacterial membrane or cellular proximity [47]. Besides, higher colloidal stability helps Fer@AgNP to be better distributed in biological environments as compared to AgNPs and to aggregate less [4850]; this phenomenon increases the probability of NPs passing through biological membranes.

Although the antimicrobial mechanism of biogenic AgNPs and chemically synthesized AgNPs is still unknown, several mechanisms can play a role in their biological activities. When synthesized with various plant extracts, AgNPs can physically attach to bacteria and even eukaryotic cell surfaces and disrupt their integrity [51]. Internalization of the cytoplasm, interaction with cellular organelles and macromolecules, and finally production of reactive oxygen species (ROS) are the main biological mechanisms of biogenic AgNPs in the literature [52]. It is known that enhancement of ROS capacity causes membrane damage by increasing permeability, leading to the disruption of the electron transfer chain and leakage of the cellular content. Besides, it can alternatively damage human cells and cause severe adverse effects. Therefore, in this study, we evaluated the effect of Fer@AgNPs on a cancerous human cell line as an indicator of cytotoxic effect and an anticancer agent.

3.4. Cytotoxic Effect of Fer@AgNPs

Several studies have assessed the anticancer effects of plant extracts. However, there is no report or article on the efficacy of synthesized Fer@AgNP in the selected cell lines. In this study, the effects of FerEX, AgNP, and Fer@AgNP were assessed on the MCF-7 human cell line by the MTT assay. Figure 7 shows that both NPs (AgNP and Fer@AgNP) showed increased cytotoxic effects against the MCF-7 cell lines at concentrations from 200 to 500 μg/mL in comparison with FerEX. By decreasing the concentration, the impact of compounds is essentially reduced. Based on the findings, at concentrations below 200 μg/mL, the effect of FerEX on the human cell lines reduced.

On the other hand, for AgNP and Fer@AgNP, the cell survivability and antioxidant levels (IC50) were 10 and 100 μg/mL, respectively, on the MCF-7. Therefore, Fer@AgNP had no antagonistic effects on the assessed cell lines as compared to AgNP, which exerted a significant cytotoxic effect on the MCF-7 cells. So far, many attempts have been designed to distinguish the effect of silver nanoparticles against various tumors. One of the broadly acknowledged hypotheses has ascribed the potential generation of reactive oxygen species created by nanoparticles and their ions, preventing cell growth and eventually cell apoptosis [8, 53].

Finally, this study showed the plausibility of the biological synthesis of AgNPs using an aqueous extract of FerEX. The presence of thiol-containing groups, alkyl halides, and other reducing agents in the extract of FerEX allows for reducing Ag particles into NPs. The green-synthesized Fer@AgNP showed high antibacterial activity against A. baumannii. Interestingly, these green-synthesized NPs did not initiate a significant reduction in the cell viability of human adenocarcinoma cells (MCF-7), except at elevated concentrations.

The emergence of multidrug-resistant bacteria, especially in the hospital ICUs, has limited the use of standard antibiotics and has led researchers to incorporate AgNPs and natural products. In our study, A. baumannii isolated from the PICUs was eliminated using biogenic AgNPs. This nanomaterial is more advantageous than chemically synthesized AgNPs and even conventional antimicrobial agents. Therefore, developing this type of NPs can be considered an alternative strategy to overcome multidrug resistance in bacteria, especially Acinetobacter strains in ICUs.

Future studies need to examine the long-term aspects of antimicrobial activity, such as inhibition of biofilm formation, and investigate the other potential advantages of this biogenic AgNP, especially in terms of biocompatibility and biodegradability. Overall, finding newer antimicrobial agents using biocompatible nanomaterials is essential to eradicate nosocomial infections, especially those caused by A. baumannii. According to the present study, Fer@AgNPs could be an excellent option to overcome these infections, possibly at lower and less toxic concentrations than what is used clinically today. Also, the combination of this biogenic nanomaterial with effective antibiotics, such as carbapenem, can be investigated in future studies.

4. Conclusion

This study is the first extensive report to demonstrate the antibacterial activity of biogenic AgNPs against a nosocomial pathogen (A. baumannii) and evaluate its human cell cytotoxicity. The biogenic NPs exhibited significant antibacterial activities against this ESKAPE pathogen. The AgNPs produced by F. asafoetida inhibited bacterial growth and showed a higher potency compared to chemically synthesized AgNPs, which might be due to disruptions in the cell wall and formation of ROS. The cytotoxic assessments showed the acceptable biocompatibility of Fer@AgNPs at lower concentrations. However, it should be noted that killing bacteria is highly specific to bacterial strains in terms of cell wall composition, growth rate, biofilm formation capacity, and type of NPs. Overall, different synthesizing procedures, sizes, and shapes can render AgNPs with variable antimicrobial properties. Moreover, the binding of NPs to any microorganism depends on interactions in the available surface area. Therefore, small-sized AgNPs with a larger surface area would exhibit a more significant microbicidal activity as compared to larger AgNPs.

Data Availability

The experimental data used to support the findings of this study are included within the article.

Conflicts of Interest

The authors declare that they have no conflicts of interest.


This study was carried out after obtaining a grant (No. 98-01-36-21987). It was funded by the Vice-Chancellor for Research Affairs of Shiraz University of Medical Sciences, Shiraz, Iran. We wish to thank H. Argasi at the Research Consultation Center (RCC) of Shiraz University of Medical Sciences for his invaluable assistance in editing this manuscript.


  1. V. Tiwari, R. Roy, and M. Tiwari, “Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens,” Frontiers in Microbiology, vol. 6, p. 618, 2015. View at: Publisher Site | Google Scholar
  2. H. Richet and P. E. Fournier, “Nosocomial infections caused by Acinetobacter baumannii a major threat worldwide,” Infection Control & Hospital Epidemiology, vol. 27, no. 7, pp. 645-646, 2006. View at: Publisher Site | Google Scholar
  3. A. Y. Peleg, H. Seifert, and D. L. Paterson, “Acinetobacter baumannii: emergence of a successful pathogen,” Clinical microbiology reviews., vol. 21, no. 3, pp. 538–582, 2008. View at: Publisher Site | Google Scholar
  4. A. Čiginskienė, A. Dambrauskienė, J. Rello, and D. Adukauskienė, “Ventilator-associated pneumonia due to drug-resistant Acinetobacter baumannii: risk factors and mortality relation with resistance profiles, and independent predictors of in-hospital mortality,” Medicina (Kaunas, Lithuania), vol. 55, no. 2, p. 49, 2019. View at: Publisher Site | Google Scholar
  5. M. Nabavizadeh, A. Abbaszadegan, A. Gholami et al., “Antibiofilm efficacy of positively charged imidazolium-based silver nanoparticles in Enterococcus faecalis using quantitative real-time PCR,” Jundishapur J Microbiol., vol. 10, no. 10, 2017. View at: Publisher Site | Google Scholar
  6. A. Abbaszadegan, A. Gholami, S. Abbaszadegan et al., “The effects of different ionic liquid coatings and the length of alkyl chain on antimicrobial and cytotoxic properties of silver nanoparticles,” Iranian endodontic journal., vol. 12, no. 4, pp. 481–487, 2017. View at: Publisher Site | Google Scholar
  7. A. Abbaszadegan, M. Nabavizadeh, A. Gholami et al., “Positively charged imidazolium-based ionic liquid-protected silver nanoparticles: a promising disinfectant in root canal treatment,” International Endodontic Journal, vol. 48, no. 8, pp. 790–800, 2015. View at: Publisher Site | Google Scholar
  8. S. Zargarnezhad, A. Gholami, M. Khoshneviszadeh, S. N. Abootalebi, and Y. Ghasemi, “Antimicrobial activity of isoniazid in conjugation with surface-modified magnetic nanoparticles against Mycobacterium tuberculosis and nonmycobacterial microorganisms,” Journal of Nanomaterials, vol. 2020, Article ID 7372531, 9 pages, 2020. View at: Publisher Site | Google Scholar
  9. A. Amalraj and S. Gopi, “Biological activities and medicinal properties of Asafoetida: a review,” Journal of Traditional and Complementary Medicine, vol. 7, no. 3, pp. 347–359, 2017. View at: Publisher Site | Google Scholar
  10. S. Sarkar and V. Kotteeswaran, “Green synthesis of silver nanoparticles from aqueous leaf extract of pomegranate (Punica granatum) and their anticancer activity on human cervical cancer cells,” Advances in Natural Sciences: Nanoscience and Nanotechnology, vol. 9, no. 2, article 025014, 2018. View at: Publisher Site | Google Scholar
  11. G. Arya, R. M. Kumari, N. Sharma et al., “Catalytic, antibacterial and antibiofilm efficacy of biosynthesised silver nanoparticles using Prosopis juliflora leaf extract along with their wound healing potential,” Journal of Photochemistry and Photobiology B: Biology, vol. 190, pp. 50–58, 2019. View at: Publisher Site | Google Scholar
  12. G. Arya, R. Mankamna Kumari, N. Sharma et al., “Evaluation of antibiofilm and catalytic activity of biogenic silver nanoparticles synthesized fromAcacia niloticaleaf extract,” Advances in Natural Sciences: Nanoscience and Nanotechnology, vol. 9, no. 4, article 045003, 2018. View at: Publisher Site | Google Scholar
  13. A. Gholami, S. Shahin, M. Mohkam, N. Nezafat, and Y. Ghasemi, “Cloning, characterization and bioinformatics analysis of novel cytosine deaminase from Escherichia coli AGH09,” International Journal of Peptide Research and Therapeutics., vol. 21, no. 3, pp. 365–374, 2015. View at: Publisher Site | Google Scholar
  14. S. N. Abootalebi, A. Saeed, A. Gholami et al., “Screening, characterization and production of thermostable alpha-amylase produced by a novel thermophilic Bacillus megaterium isolated from pediatric intensive care unit,” Journal of Environmental Treatment Techniques, vol. 8, no. 3, pp. 952–960, 2020. View at: Google Scholar
  15. A. Abbaszadegan, S. Sahebi, A. Gholami et al., “Time-dependent antibacterial effects of Aloe vera and Zataria multiflora plant essential oils compared to calcium hydroxide in teeth infected with Enterococcus faecalis,” Journal of Investigative and Clinical Dentistry, vol. 7, no. 1, pp. 93–101, 2016. View at: Publisher Site | Google Scholar
  16. M. S. Asgari, S. Sepehri, S. Bahadorikhalili et al., “Magnetic silica nanoparticle-supported copper complex as an efficient catalyst for the synthesis of novel triazolopyrazinylacetamides with improved antibacterial activity,” Chemistry of Heterocyclic Compounds, vol. 56, no. 4, pp. 488–494, 2020. View at: Publisher Site | Google Scholar
  17. F. Moazami, A. Gholami, V. Mehrabi, and Y. Ghahramani, “Evaluation of the antibacterial and antifungal effects of ProRoot MTA and nano-fast cement: an In Vitro study,” Journal of Contemporary Dental Practice, vol. 21, no. 7, pp. 760–764, 2020. View at: Google Scholar
  18. A. Gholami, S. Rasoul-amini, A. Ebrahiminezhad, S. H. Seradj, and Y. Ghasemi, “Lipoamino acid coated superparamagnetic iron oxide nanoparticles concentration and time dependently enhanced growth of human hepatocarcinoma cell line (Hep-G2),” Journal of Nanomaterials, vol. 2015, Article ID 451405, 9 pages, 2015. View at: Publisher Site | Google Scholar
  19. R. Heiran, S. Sepehri, A. Jarrahpour et al., “Synthesis, docking and evaluation of in vitro anti-inflammatory activity of novel morpholine capped β-lactam derivatives,” Bioorganic Chemistry, vol. 102, article 104091, 2020. View at: Publisher Site | Google Scholar
  20. F. Farhadi, M. Iranshahi, S. F. Taghizadeh, and J. Asili, “Volatile sulfur compounds: the possible metabolite pattern to identify the sources and types of asafoetida by headspace GC/MS analysis,” Industrial Crops and Products, vol. 155, article 112827, 2020. View at: Publisher Site | Google Scholar
  21. Y. Ichikawa, T. Watanabe, Y. Horimoto, K. Ishii, and S. Naito, “Measurements of 50 non-polar organic compounds including polycyclic aromatic hydrocarbons, n-alkanes and phthalate esters in fine particulate matter (PM 2.5) in an industrial area of Chiba prefecture, Japan,” Asian Journal of Atmospheric Environment., vol. 12, no. 3, pp. 274–288, 2018. View at: Publisher Site | Google Scholar
  22. A. Rehman, A. M. López Fernández, M. F. M. Gunam Resul, and A. Harvey, “Highly selective, sustainable synthesis of limonene cyclic carbonate from bio- based limonene oxide and CO2: a kinetic study,” Journal of CO2 Utilization, vol. 29, pp. 126–133, 2019. View at: Publisher Site | Google Scholar
  23. C. Khaleel, N. Tabanca, and G. Buchbauer, “α-Terpineol, a natural monoterpene: a review of its biological properties,” Open Chemistry, vol. 16, no. 1, pp. 349–361, 2018. View at: Publisher Site | Google Scholar
  24. H. Zengin and A. H. Baysal, “Antibacterial and antioxidant activity of essential oil terpenes against pathogenic and spoilage-forming bacteria and cell structure-activity relationships evaluated by SEM microscopy,” Molecules, vol. 19, no. 11, pp. 17773–17798, 2014. View at: Publisher Site | Google Scholar
  25. P. Rajasekar, S. Priyadharshini, T. Rajarajeshwari, and C. Shivashri, “Bio-inspired synthesis of silver nanoparticles using Andrographis paniculata whole plant extract and their antimicrobial activity overpathogenic microbes,” International Journal of Research in Biomedicine and Biotechnology, vol. 3, no. 3, pp. 47–52, 2013. View at: Google Scholar
  26. S. Devanesan, K. Ponmurugan, M. S. AlSalhi, and N. A. al- Dhabi, “Cytotoxic and antimicrobial efficacy of silver nanoparticles synthesized using a traditional phytoproduct, asafoetida gum,” International Journal of Nanomedicine, vol. 15, pp. 4351–4362, 2020. View at: Publisher Site | Google Scholar
  27. M. A. AbuDalo, I. R. al-Mheidat, A. W. al-Shurafat, C. Grinham, and V. Oyanedel-Craver, “Synthesis of silver nanoparticles using a modified Tollens’ method in conjunction with phytochemicals and assessment of their antimicrobial activity,” PeerJ, vol. 7, article e6413, 2019. View at: Publisher Site | Google Scholar
  28. W. Chartarrayawadee, P. Charoensin, J. Saenma et al., “Green synthesis and stabilization of silver nanoparticles using Lysimachia foenum-graecum Hance extract and their antibacterial activity,” Green Processing and Synthesis, vol. 9, no. 1, pp. 107–118, 2020. View at: Publisher Site | Google Scholar
  29. N. E.-A. El-Naggar, M. H. Hussein, and A. A. El-Sawah, “Phycobiliprotein-mediated synthesis of biogenic silver nanoparticles, characterization, in vitro and in vivo assessment of anticancer activities,” Scientific Reports, vol. 8, no. 1, p. 8925, 2018. View at: Publisher Site | Google Scholar
  30. S. Pirtarighat, M. Ghannadnia, and S. Baghshahi, “Green synthesis of silver nanoparticles using the plant extract of Salvia spinosa grown in vitro and their antibacterial activity assessment,” Journal of Nanostructure in Chemistry, vol. 9, no. 1, pp. 1–9, 2019. View at: Publisher Site | Google Scholar
  31. M. Ghaffari-Moghaddam, R. Hadi-Dabanlou, M. Khajeh, M. Rakhshanipour, and K. Shameli, “Green synthesis of silver nanoparticles using plant extracts,” Korean Journal of Chemical Engineering, vol. 31, no. 4, pp. 548–557, 2014. View at: Publisher Site | Google Scholar
  32. A. U. Khan, Q. Yuan, Z. U. H. Khan et al., “An eco-benign synthesis of AgNPs using aqueous extract of Longan fruit peel: antiproliferative response against human breast cancer cell line MCF-7, antioxidant and photocatalytic deprivation of methylene blue,” Journal of Photochemistry and Photobiology B: Biology, vol. 183, pp. 367–373, 2018. View at: Publisher Site | Google Scholar
  33. O. E. Rodríguez-Luis, R. Hernandez-Delgadillo, R. I. Sánchez-Nájera et al., “Green synthesis of silver nanoparticles and their bactericidal and antimycotic activities against oral microbes,” Journal of Nanomaterials, vol. 2016, Article ID 9204573, 10 pages, 2016. View at: Publisher Site | Google Scholar
  34. M. Ndikau, N. M. Noah, D. M. Andala, and E. Masika, “Green synthesis and characterization of silver nanoparticles using Citrullus lanatus fruit rind extract,” International Journal of Analytical Chemistry, vol. 2017, Article ID 8108504, 9 pages, 2017. View at: Publisher Site | Google Scholar
  35. J. Huang, G. Zhan, B. Zheng et al., “Biogenic silver nanoparticles byCacumen PlatycladiExtract: synthesis, formation mechanism, and antibacterial activity,” Industrial & Engineering Chemistry Research, vol. 50, no. 15, pp. 9095–9106, 2011. View at: Publisher Site | Google Scholar
  36. P. Tippayawat, N. Phromviyo, P. Boueroy, and A. Chompoosor, “Green synthesis of silver nanoparticles in aloe vera plant extract prepared by a hydrothermal method and their synergistic antibacterial activity,” PeerJ, vol. 4, article e2589, 2016. View at: Publisher Site | Google Scholar
  37. B. B. F. Mirjalili, S. Khabnadideh, A. Gholami et al., “Cu (OAc) 2 as a green promoter for one-pot synthesis of 2-amino-4, 6-diarylpyridine-3-carbonitrile as antibacterial agents,” Bulletin of the Chemical Society of Ethiopia, vol. 34, no. 1, pp. 149–156, 2020. View at: Publisher Site | Google Scholar
  38. G. Arya, R. M. Kumari, N. Gupta, A. Kumar, R. Chandra, and S. Nimesh, “Green synthesis of silver nanoparticles using Prosopis juliflorabark extract: reaction optimization, antimicrobial and catalytic activities,” Artificial cells, Nanomedicine, and Biotechnology, vol. 46, no. 5, pp. 985–993, 2018. View at: Publisher Site | Google Scholar
  39. S. Goyal, N. Gupta, A. Kumar, S. Chatterjee, and S. Nimesh, “Antibacterial, anticancer and antioxidant potential of silver nanoparticles engineered using Trigonella foenum‐graecum seed extract,” IET nanobiotechnology., vol. 12, no. 4, pp. 526–533, 2018. View at: Publisher Site | Google Scholar
  40. B. Sharma, I. Singh, S. Bajar, S. Gupta, H. Gautam, and P. Kumar, “Biogenic silver nanoparticles: evaluation of their biological and catalytic potential,” Indian Journal of Microbiology., vol. 60, no. 4, pp. 468–474, 2020. View at: Publisher Site | Google Scholar
  41. R. Singh, J. Vora, S. B. Nadhe, S. A. Wadhwani, U. U. Shedbalkar, and B. A. Chopade, “Antibacterial activities of bacteriagenic silver nanoparticles against nosocomial Acinetobacter baumannii,” Journal of nanoscience and nanotechnology., vol. 18, no. 6, pp. 3806–3815, 2018. View at: Publisher Site | Google Scholar
  42. L. Lin, B. Tan, P. Pantapalangkoor et al., “Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis,” MBio, vol. 3, no. 5, 2012. View at: Publisher Site | Google Scholar
  43. R. Bhatnager, R. Rani, and A. S. Dang, “Antibacterial activity of Ferula asafoetida: a comparison of red and white type,” Journal of Applied Biology & Biotechnology, vol. 3, pp. 18–21, 2015. View at: Google Scholar
  44. F. A. Alharbi and A. A. Alarfaj, “Green synthesis of silver nanoparticles from Neurada procumbens and its antibacterial activity against multi-drug resistant microbial pathogens,” Journal of King Saud University - Science, vol. 32, no. 2, pp. 1346–1352, 2020. View at: Publisher Site | Google Scholar
  45. K. Silva Santos, A. M. Barbosa, L. Pereira da Costa, M. S. Pinheiro, M. B. P. P. Oliveira, and F. Ferreira Padilha, “Silver nanocomposite biosynthesis: antibacterial activity against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii,” Molecules, vol. 21, no. 9, p. 1255, 2016. View at: Publisher Site | Google Scholar
  46. P. Wintachai, S. Paosen, C. T. Yupanqui, and S. P. Voravuthikunchai, “Silver nanoparticles synthesized with Eucalyptus critriodora ethanol leaf extract stimulate antibacterial activity against clinically multidrug-resistant Acinetobacter baumannii isolated from pneumonia patients,” Microbial Pathogenesis, vol. 126, pp. 245–257, 2019. View at: Publisher Site | Google Scholar
  47. A. S. Ethiraj, S. Jayanthi, C. Ramalingam, and C. Banerjee, “Control of size and antimicrobial activity of green synthesized silver nanoparticles,” Materials Letters, vol. 185, pp. 526–529, 2016. View at: Publisher Site | Google Scholar
  48. A. Gholami, S. M. Mousavi, S. A. Hashemi, Y. Ghasemi, W.-H. Chiang, and N. Parvin, “Current trends in chemical modifications of magnetic nanoparticles for targeted drug delivery in cancer chemotherapy,” Drug Metabolism Reviews, vol. 52, no. 1, pp. 205–224, 2020. View at: Publisher Site | Google Scholar
  49. F. Emadi, A. Emadi, and A. Gholami, “A comprehensive insight towards pharmaceutical aspects of graphene nanosheets,” Current Pharmaceutical Biotechnology, vol. 21, no. 11, pp. 1016–1027, 2020. View at: Publisher Site | Google Scholar
  50. A. Abbaszadegan, Y. Ghahramani, M. Farshad, M. Sedigh-Shams, A. Gholami, and A. Jamshidzadeh, “In vitro evaluation of dynamic viscosity, surface tension and dentin wettability of silver nanoparticles as an irrigation solution,” Iranian Endodontic Journal, vol. 14, no. 1, pp. 23–27, 2019. View at: Google Scholar
  51. E. O. Mikhailova, “Silver Nanoparticles: Mechanism of action and probable bio-application,” Journal of Functional Biomaterials, vol. 11, no. 4, p. 84, 2020. View at: Publisher Site | Google Scholar
  52. A. Roy, O. Bulut, S. Some, A. K. Mandal, and M. D. Yilmaz, “Green synthesis of silver nanoparticles: biomolecule-nanoparticle organizations targeting antimicrobial activity,” RSC Advances, vol. 9, no. 5, pp. 2673–2702, 2019. View at: Publisher Site | Google Scholar
  53. F. Mohammadi, A. Abbaszadegan, and A. Gholami, “Recent advances in nanodentistry: a special focus on endodontics,” Micro & Nano Letters, vol. 15, no. 12, pp. 812–816, 2020. View at: Publisher Site | Google Scholar

Copyright © 2021 Seyedeh Narjes Abootalebi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.